Abstract: A method and apparatus of image coding including a no-residue prediction mode are disclosed. At the encoder side, current predictors for a current coding unit are determined according to a target prediction process associated with a target prediction mode. The current predictors are determined based on pixel data including reconstructed pixels in the current slice or the current image. The target prediction process is applied to the current coding unit using the current predictors to generate prediction residues. A distortion condition or a cost measure for the prediction residues is determined. If the distortion condition is satisfied or the cost measure favors coding without the prediction residues, the current coding unit is encoded into current compressed bits of the current coding unit without compressed data associated with the prediction residues. A corresponding decoding method and apparatus are also disclosed.

Abstract: A method and apparatus of image coding including adaptive entropy coding are disclosed. According to this method, input pixels associated with a group of symbols generated from image or video data are received. Maximum bit-depth of the group of symbols is then determined. If the maximum bit-depth of the group of symbols is smaller than a first bit-depth threshold, the group of symbols is encoded or decoded using Golomb-Rice coding. If the maximum bit-depth of the group of symbols is greater than or equal to the first bit-depth threshold, the group of symbols is encoded or decoded using second entropy coding, where the second entropy coding is different from the Golomb-Rice coding. Outputs corresponding to encoded or decoded output associated with the group of symbols are provided. The maximum bit-depth of the group of symbols is signaled at the encoder or recovered at the decoder by parsing the bitstream.

Abstract: Method and apparatus of image coding using block prediction (BP) allowing multiple block sizes are disclosed. According to one method, first distortion for the current block coded using BP with a first block size is derived using at least partial second distortion for the current block coded using BP with a first block size. According to another method, a flag indicating whether the BP using variable block sizes is enabled. According to yet another method, when a current block is coded using BP by partitioning the current block into multiple partitions, predictors for two partitions in different reconstructed pixel line groups are derived from different reconstructed pixel line groups. According to still yet another method, for coding image data in a non-444 color sampling format using BP, the predictors for chrominance pixels in the current block are derived from the predictors for the luminance pixels of the current block.

Abstract: A method and apparatus of coding using multiple coding modes with multiple color spaces are provided. For the encoder side, a coding mode is selected from a coding mode group. A corresponding color domain is associated with the coding mode and the corresponding color domain is selected from a color-domain group including at least two different color domains. The current coding unit is then encoded in the corresponding color domain using the coding mode. Furthermore, the syntax of the corresponding color domain is signaled in current coding unit syntaxes. The different color domains may include RGB color domain and YCoCg color domain. According to another method, if the midpoint prediction (MPP) mode is selected, a current block is color transformed into another color domain and the MPP coding process is performed in said another color domain.

Abstract: A method and apparatus of encoding using multiple coding modes with multiple color spaces are disclosed. Weighted distortion is calculated for each candidate mode and a target mode is selected according to information including the weighted distortion. Each candidate coding mode is selected from a coding mode group including at least a first coding mode and a second coding mode, where the first coding mode uses a first color space for encoding one block and the second coding mode uses a second color space for encoding one block, and the first color space is different from the second color space. The weighted distortion corresponds to a weighted sum of distortions of color channels for each color transformed current block using a set of weighting factors and the set of weighting factors is derived based on a color transform associated with a corresponding color space for each coding mode.

Abstract: A method and apparatus of encoding frames with a frame type structure adaptively according to a current encoding status after receiving a request for an IDR frame or receiving an indication of picture data loss are disclosed. If the check result of the current encoding status is true, the second frame type structure is the same as the first frame type structure; and if the check result of the current encoding status is false, the second frame type structure is different from the first frame type structure. Another method and apparatus of encoding frames with a reference frame structure and a frame type structure adaptively according to one or more current encoding statuses after receiving an indication of picture data loss are disclosed. The system may use two different check results to adaptively select the reference frame structure and the frame type structure.

Abstract: A UGT2B inhibitor capable of increasing the bio-availability of a drug, is a compound in a free base or a pharmaceutically acceptable salt form that is selected from the group consisting of: capillarisin, isorhamnetin, ?-naphthoflavone, ?-naphthoflavone, hesperetin, terpineol, (+)-limonene, ?-myrcene, swertiamarin, eriodictyol, cineole, apigenin, baicalin, ursolic acid, isovitexin, lauryl alcohol, puerarin, trans-cinnamaldehyde, 3-phenylpropyl acetate, isoliquritigenin, paeoniflorin, gallic acid, genistein, glycyrrhizin, protocatechuic acid, ethyl myristate, umbelliferone, PEG (Polyethylene glycol) 400, PEG 2000, PEG 4000, Tween 20, Tween 60, Tween 80, BRIJ® 58, BRIJ® 76, Pluronic® F68, Pluronic® F127, and a combination thereof.

Abstract: A UGT2B inhibitor capable of increasing the bio-availability of a drug, is a compound in a free base or a pharmaceutically acceptable salt form that is selected from the group consisting of: capillarisin, isorhamnetin,?-naphthoflavone, ?-naphthoflavone, hesperetin, terpineol, (+)-limonene, ?-myrcene, swertiamarin, eriodictyol, cineole, apigenin, baicalin, ursolic acid, isovitexin, lauryl alcohol, puerarin, trans-cinnamaldehyde, 3-phenylpropyl acetate, isoliquritigenin, paeoniflorin, gallic acid, genistein, glycyrrhizin, protocatechuic acid, ethyl myristate, umbelliferone, PEG (Polyethylene glycol) 400, PEG 2000, PEG 4000, Tween 20, Tween 60, Tween 80, BRIJ® 58, BRIJ® 76, Pluronic® F68, Pluronic® F127, and a combination thereof.

Abstract: An assistance device includes a body having two wheels, and a pivotal device located in the body. Two transmission units are pivotably connected to the pivotal device by two shafts. A restriction unit includes a first link, a second link and a rail which is connected to the body. The first link has the first end pivotably connected to one of the two transmission units. The second link is pivotably connected to the other one of the two transmission units. A roller is connected to the first end of the second link and movable along the rail. A leg having a top end to which the second end of the first link is pivotably connected. The second end of the second link is pivotably connected between the top end and the lower end of the leg. The leg contacts against the ground to lift the body to climb stairs.

Abstract: The present invention relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against influenza virus. The present invention also relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against drug-resistant influenza virus strains. The present invention is further related to a method for treating influenza in a subject, comprising administering to said subject an effective amount of mycophenolate mofetil or a pharmaceutically acceptable salt thereof.

Abstract: A microscopy imaging system and method for rendering a mosaic representation of an object from a series of image frames of the object are disclosed. A current image frame is processed to determine its relative location or position within the mosaic representation based on relative displacement of the current image from one or more keyframes. Once the current image frame's position has been determined, it is rendered along with its neighboring keyframes to provide the mosaic representation of the object.

Abstract: A method for alleviating at least one of the disturbance of bile acid metabolism, the disturbance of amino acid metabolism, and the disturbance of gut microbiota metabolism in a subject, comprising administering to the subject a composition or a health food comprising an active component selected from the group consisting of gallic acid, a pharmaceutically acceptable salt of gallic acid, a pharmaceutically acceptable ester of gallic acid, and combinations thereof.

Abstract: This invention is to provide multiple specific inhibitors of cytochrome P450 isozyme CYP2C9. These inhibitors can be derived from any combinations with the following compounds including: Tamarixetin, Formononetin, isoliquritigenin, Phloretin, luteolin, Quercitrin, quercetin, myricetin, Wongonin, Puerarin, Genistein, Nordihydroguaiaretic acid, Narigenin, Capillarisin, Chrysin, Fisefin, eriodictyol, 6-Gingerol, Isorhamneti, isoquercitrin, Morin, (+)-Taxifolin, isovitexin, 3-Phenylpropyl Acetate, Oleanolic acid, ursolic acid, ?-Myrcene, cinnamic acid, Luteolin-7-Glucoside, Liquiritin, (+)Limonene, Homoorientin, Swertiamarin, Embelin, Daidzein, Poncirin, (?)-Epicatechin, ergosterol. These natural products can be used to enhance the bioavailability of therapeutic agents (drugs).

Abstract: The present invention provides a wideband frequency tunable ring resonator, wherein, comprises a closed ?g/2 transmission line and two variable capacitors with tunable capacitance, the ?g/2 transmission line is axisymmetric around a central line, first ends of the two variable capacitors are respectively connected to two intersection points of the ?g/2 transmission line and the central line, the second ends of the two variable capacitors are respectively grounded. By implementing the technical solution of present invention, following technical effects are obtained. The fundamental resonant frequency (ffund) can be shifted up and down by controlling the respective values of the two loading capacitors, resulting in a bi-directional tuning of ffund. As a result, the tuning range of this invention can be approximately doubled as compared with the conventional tunable ring resonator.

Abstract: A microscopy imaging system and method for rendering a mosaic representation of an object from a series of image frames of the object are disclosed. A current image frame is processed to determine its relative location or position within the mosaic representation based on relative displacement of the current image from one or more keyframes. Once the current image frame's position has been determined, it is rendered along with its neighboring keyframes to provide the mosaic representation of the object.

Abstract: A microwave frequency tunable filtering balun is provided. The microwave frequency tunable filtering balun comprises a first microwave split ring transmission line resonator and a second microwave split ring transmission line resonator arranged in a bilaterally symmetrical manner, a fourth variable capacitor and a fifth variable capacitor of same parameters. It combines two functions of balun and tunable bandpass filter (BPF) into one circuit, resulting in a compact design. The balun characteristic and frequency-tuning mechanism are investigated, and the design equations are derived.

Abstract: A cutting apparatus configured for aligned with a gate of an injection molding part, includes a bottom board, a main adjustable mechanism attached to the bottom board, and a cutting mechanism. The main adjustable mechanism includes a driving device, a mounting member attached to the driving device, and a rotatable member rotatably attached to the mounting member. The rotatable member can be rotatable relative to the mounting member between a first position, where an acute angle is formed between the rotatable member and the mounting member, and a second position, where the rotatable member parallel to and abuts the mounting member.

Abstract: A microwave frequency tunable filtering balun is provided. The microwave frequency tunable filtering balun comprises a first microwave split ring transmission line resonator and a second microwave split ring transmission line resonator arranged in a bilaterally symmetrical manner, a fourth variable capacitor and a fifth variable capacitor of same parameters. It combines two functions of balun and tunable bandpass filter (BPF) into one circuit, resulting in a compact design. The balun characteristic and frequency-tuning mechanism are investigated, and the design equations are derived.

Abstract: This invention is to provide multiple specific inhibitors of cytochrome P450 isozyme CYP2C9. These inhibitors can be derived from any combinations with the following compounds including: Tamarixetin, Formononetin, isoliquritigenin, Phloretin, luteolin, Quercitrin, quercetin, myricetin, Wongonin, Puerarin, Genistein, Nordihydroguaiaretic acid, Narigenin, Capillarisin, Chrysin, Fisefin, eriodictyol, 6-Gingerol, Isorhamneti, isoquercitrin, Morin, (+)-Taxifolin, isovitexin, 3-Phenylpropyl Acetate, Oleanolic acid, ursolic acid, ?-Myrcene, cinnamic acid, Luteolin-7-Glucoside, Liquiritin, (+) Limonene, Homoorientin, Swertiamarin, Embelin, Daidzein, Poncirin, (?)-Epicatechin, ergosterol. These natural products can be used to enhance the bioavailability of therapeutic agents (drugs).

Abstract: This invention relates to a process for preparing a pharmaceutical composition comprising four antitubercular drugs: rifampin or a pharmaceutically acceptable salt thereof, isoniazid or a pharmaceutically acceptable salt thereof, pyrazinamide or a pharmaceutically acceptable salt thereof and ethambutol or a pharmaceutically acceptable salt thereof, wherein rifampin and isoniazid are in separate layers. The invention also provides a pharmaceutical composition prepared therefrom having advantageous stability and bioavailability.